Cargando…

Retracted: Efficacy Evaluation of Inflammatory Mediators in the Treatment of Multiple Myeloma with Daratumumab

Detalles Bibliográficos
Autor principal: Oncology, Journal of
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356497/
https://www.ncbi.nlm.nih.gov/pubmed/37476549
http://dx.doi.org/10.1155/2023/9832530
_version_ 1785075290010025984
author Oncology, Journal of
author_facet Oncology, Journal of
author_sort Oncology, Journal of
collection PubMed
description
format Online
Article
Text
id pubmed-10356497
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103564972023-07-20 Retracted: Efficacy Evaluation of Inflammatory Mediators in the Treatment of Multiple Myeloma with Daratumumab Oncology, Journal of J Oncol Retraction Hindawi 2023-07-12 /pmc/articles/PMC10356497/ /pubmed/37476549 http://dx.doi.org/10.1155/2023/9832530 Text en Copyright © 2023 Journal of Oncology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Oncology, Journal of
Retracted: Efficacy Evaluation of Inflammatory Mediators in the Treatment of Multiple Myeloma with Daratumumab
title Retracted: Efficacy Evaluation of Inflammatory Mediators in the Treatment of Multiple Myeloma with Daratumumab
title_full Retracted: Efficacy Evaluation of Inflammatory Mediators in the Treatment of Multiple Myeloma with Daratumumab
title_fullStr Retracted: Efficacy Evaluation of Inflammatory Mediators in the Treatment of Multiple Myeloma with Daratumumab
title_full_unstemmed Retracted: Efficacy Evaluation of Inflammatory Mediators in the Treatment of Multiple Myeloma with Daratumumab
title_short Retracted: Efficacy Evaluation of Inflammatory Mediators in the Treatment of Multiple Myeloma with Daratumumab
title_sort retracted: efficacy evaluation of inflammatory mediators in the treatment of multiple myeloma with daratumumab
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356497/
https://www.ncbi.nlm.nih.gov/pubmed/37476549
http://dx.doi.org/10.1155/2023/9832530
work_keys_str_mv AT oncologyjournalof retractedefficacyevaluationofinflammatorymediatorsinthetreatmentofmultiplemyelomawithdaratumumab